These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16007064)

  • 1. [Algorithm of diagnosis and treatment of metabolic syndrome].
    Mamedov MN
    Kardiologiia; 2005; 45(5):92-100. PubMed ID: 16007064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic syndrome from the point of view of a cardiologist: diagnosis, non drug and drug treatment].
    Makolkin VI; Podzolkov VI; Napalkov DA
    Kardiologiia; 2002; 42(12):91-7. PubMed ID: 12494026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of the metabolic syndrome in the elderly.
    Firdaus M
    J Okla State Med Assoc; 2005 Feb; 98(2):63-6. PubMed ID: 15789643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome: Insulin Resistance and Prediabetes.
    Mayans L
    FP Essent; 2015 Aug; 435():11-6. PubMed ID: 26280340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance syndrome. Description, pathogenesis, and management.
    Miller JL
    Postgrad Med; 2003 May; Spec No():27-34. PubMed ID: 12785129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome.
    Davidson MH
    Am J Cardiol; 2004 Jun; 93(11A):3C-11C. PubMed ID: 15178511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk reduction therapy for syndrome X: comparison of several treatments.
    Oron-Herman M; Sela BA; Rosenthal T
    Am J Hypertens; 2005 Mar; 18(3):372-8. PubMed ID: 15797656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity?
    Bulcão C; Giuffrida FM; Ribeiro-Filho FF; Ferreira SR
    Braz J Med Biol Res; 2007 Feb; 40(2):229-35. PubMed ID: 17273659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of hypertension in patients with type 2 diabetes mellitus].
    Hess K
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2489-92. PubMed ID: 23114910
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic syndrome: screening, diagnosis, and management.
    Miller EL; Mitchell A
    J Midwifery Womens Health; 2006; 51(3):141-51. PubMed ID: 16647666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk.
    Smith SR
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():128S-134S. PubMed ID: 16931494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on the effects of Allium sativum (Garlic) in metabolic syndrome.
    Hosseini A; Hosseinzadeh H
    J Endocrinol Invest; 2015 Nov; 38(11):1147-57. PubMed ID: 26036599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using insulin as a drug rather than as a replacement hormone during acute illness: a new paradigm.
    Pantaleo A; Zonszein J
    Heart Dis; 2003; 5(5):323-33. PubMed ID: 14503930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome update.
    Grundy SM
    Trends Cardiovasc Med; 2016 May; 26(4):364-73. PubMed ID: 26654259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
    Schindler C
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.